Mental Disorders

274 trials 116 recruiting

Filter these 274 trials by phase, country and sponsor.

Open in Search →

Microdosing for ADHD and emotion regulation Not authorised

2025-520906-36-00 Attention Deficit Hyperactivity Disorder (ADHD) 4
An open label safety and efficacy study of allogenic adipose tissue-derived mesenchymal stromal cells on autism and gastrointestinal symptom… Not authorised

2025-523699-21-00 Gastrointestinal symptoms 3
The Acute and Long-term Impact of Support and Music in Psilocybin Therapy for Depression: The Psilocybin Setting Trial (PSISET) Not authorised

2025-522961-31-00 Depression 4
Can the Gut Help Fight Addiction? A Clinical Study on Rifaximin and the Microbiota–Brain Connection Not authorised

2025-524778-41-00 substance use disorder 4
A one-year study to assess if Xanomeline/Trospium (XT) can improve cognitive function in adults living with schizophrenia. Not authorised

2025-523060-20-00 Schizophrenia 5
Psilocybin's effects on anhedonia Not authorised

2023-509009-59-00 Major Depressive Disorder 3
The additive effect of ketamine in combination with electroconvulsive stimulation (ECS) in major depressive disorder (MDD): a translational … Not authorised

2024-512559-20-00 Major Depressive Disorder (MDD) 5
A randomised, controlled trial to investigate the effect of a four/six week intensified pharmacological treatment for schizophrenia, major d… Not authorised

2022-502185-24-00 Schizophrenia, schizoaffective disorder, schizophrenifo 5
Pharmacological treatment of compulsive sexual behaviour disorder Not authorised

2024-514490-22-00 Compulsive Sexual Behaviour Disorder 5
First administration in healthy volunteers of a single and increasing dose of a new molecule for the treatment of brain diseases Not authorised

2023-505030-99-00 Post-Traumatic Stress Disorder (PTSD) 1
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose crossover, bioavailability study comparing Bupropi… Pending

2025-523410-84-00 Seasonal affective disorder 2
An open label, balanced, randomized, three treatment, three period, three sequence, single dose, crossover study to assess the effect of foo… Pending

2025-523411-11-00 Seasonal affective disorder 3
Prevention of Sexual Offending with Cognitive Behavioral Therapy Alone Versus Therapy Combined with Testosterone Suppression – the PREVENT-M… Pending

2024-518120-68-01 Paraphilic disorder, Compulsive sexual behavior disorde 4
Psilocybin in treatment-resistant depression Pending

2024-518654-16-01 Treatment-resistant depression 4
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression) - X-CE… Pending

2025-522775-29-00 Depressive episodes associated with Bipolar disorder I 5
A PET Study to Assess the Occupancy of M4 Muscarinic Acetylcholine Receptors by BMS-986521 in Healthy Adult Participants Pending

2025-524564-38-00 Neuropsychiatric indications and potentially other cond 3
Unraveling the aesthetic mind in anhedonia, insights from pharmacological imaging of the human brain: A single-blind, randomized, placebo-co… Pending

2024-517252-35-00 Depression 3
Use of low doses of interleukin-2 in autism spectrum disorders Pending

2025-522841-23-00 Autism Spectrum disorder ASD 4
EPABID: Efficacy of Pipamperone and Aripiprazole on Behaviors that challenge in Intellectual Disabilities Pending

2024-519833-51-00 Behaviors that challenge 6
Efficacy of EMONO as an add-on therapy to conventional antidepressants for the treatment of depressive symptoms in nursing-home residents wi… Pending

2023-504691-18-00 psychiatry 4
Clinical trial to determine the efficacy and safety of AP707 in the treatment of Borderline Personality Disorder Pending

2024-510873-11-00 Borderline personality disorder 4
An Open-label Study of Azetukalner in Bipolar I or II Depression Pending

2025-522872-10-00 Depressive episodes associated with Bipolar disorder I 5
Effect of faecal microbiota transplant on the expression of autism spectrum disorder core symptoms in children – open-label phase II clinica… Pending

2025-524673-16-00 Autism spectrum disorder 4
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND) Pending

2024-516805-22-00 Major Depressive Disorder 5